Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - OTHER CURRENT LIABILITIES
Other Current Liabilities TRVI - Trevi Therapeutics, Inc.
3.71 M
LAST VALUE
-2.75%
2 YEAR CAGR
12.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR